Novartis places big, broad bet on cancer immunotherapy

ReutersNovartis places big, broad bet on cancer immunotherapyReutersNovartis is well placed in the hot field of cancer immunotherapy, despite being behind rivals in developing immune system-boosting drugs known as checkpoint inhibitors, a top executive at the Swiss drugmaker said on Monday. "We will play an important ...and more »

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel